• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 的蛋白酶 PLpro 和 3CLpro 可切割 IRF3 以及炎症途径的关键调节剂(NLRP12 和 TAB1):对跨物种疾病表现的影响。

SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.

机构信息

EMBL Australia Node for Single Molecule Sciences, and School of Medical Sciences, Botany Road, The University of New South Wales, Sydney, Australia.

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

出版信息

Emerg Microbes Infect. 2021 Dec;10(1):178-195. doi: 10.1080/22221751.2020.1870414.

DOI:10.1080/22221751.2020.1870414
PMID:33372854
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7850364/
Abstract

The genome of SARS-CoV-2 encodes two viral proteases (NSP3/papain-like protease and NSP5/3C-like protease) that are responsible for cleaving viral polyproteins during replication. Here, we discovered new functions of the NSP3 and NSP5 proteases of SARS-CoV-2, demonstrating that they could directly cleave proteins involved in the host innate immune response. We identified 3 proteins that were specifically and selectively cleaved by NSP3 or NSP5: IRF-3, and NLRP12 and TAB1, respectively. Direct cleavage of IRF3 by NSP3 could explain the blunted Type-I IFN response seen during SARS-CoV-2 infections while NSP5 mediated cleavage of NLRP12 and TAB1 point to a molecular mechanism for enhanced production of cytokines and inflammatory responThe genome of SARS-CoV-2 encodes two viral proteases (NSP3/papain-like protease and NSP5/3C-like protease) that are responsible for cleaving viral polyproteins during replication. Here, we discovered new functions of the NSP3 and NSP5 proteases of SARS-CoV-2, demonstrating that they could directly cleave proteins involved in the host innate immune response. We identified 3 proteins that were specifically and selectively cleaved by NSP3 or NSP5: IRF-3, and NLRP12 and TAB1, respectively. Direct cleavage of IRF3 by NSP3 could explain the blunted Type-I IFN response seen during SARS-CoV-2 infections while NSP5 mediated cleavage of NLRP12 and TAB1 point to a molecular mechanism for enhanced production of cytokines and inflammatory response observed in COVID-19 patients. We demonstrate that in the mouse NLRP12 protein, one of the recognition site is not cleaved in our assay. We pushed this comparative alignment of IRF-3 and NLRP12 homologs and show that the lack or presence of cognate cleavage motifs in IRF-3 and NLRP12 could contribute to the presentation of disease in cats and tigers, for example. Our findings provide an explanatory framework for indepth studies into the pathophysiology of COVID-19.

摘要

SARS-CoV-2 的基因组编码两种病毒蛋白酶(NSP3/木瓜蛋白酶样蛋白酶和 NSP5/3C 样蛋白酶),它们负责在复制过程中切割病毒多蛋白。在这里,我们发现了 SARS-CoV-2 的 NSP3 和 NSP5 蛋白酶的新功能,证明它们可以直接切割参与宿主先天免疫反应的蛋白质。我们鉴定了 3 种被 NSP3 或 NSP5 特异性和选择性切割的蛋白质:IRF-3 以及 NLRP12 和 TAB1。NSP3 对 IRF3 的直接切割可以解释 SARS-CoV-2 感染期间观察到的 I 型 IFN 反应迟钝,而 NSP5 介导的 NLRP12 和 TAB1 的切割表明了增强细胞因子和炎症反应的分子机制。在 COVID-19 患者中观察到。我们证明在小鼠 NLRP12 蛋白中,我们的测定中没有切割一个识别位点。我们推动了 IRF-3 和 NLRP12 同源物的这种比较性比对,并表明 IRF-3 和 NLRP12 中同源切割基序的缺失或存在可能导致猫和老虎出现疾病。我们的发现为深入研究 COVID-19 的病理生理学提供了一个解释框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd4/7850364/9fde1f5caa39/TEMI_A_1870414_F0008_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd4/7850364/680c6d683111/TEMI_A_1870414_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd4/7850364/047138ca73ab/TEMI_A_1870414_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd4/7850364/94a1e19ec468/TEMI_A_1870414_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd4/7850364/b3edc715fc88/TEMI_A_1870414_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd4/7850364/3abb1945018a/TEMI_A_1870414_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd4/7850364/c2326d555ca5/TEMI_A_1870414_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd4/7850364/8d3f6650e5c5/TEMI_A_1870414_F0007_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd4/7850364/9fde1f5caa39/TEMI_A_1870414_F0008_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd4/7850364/680c6d683111/TEMI_A_1870414_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd4/7850364/047138ca73ab/TEMI_A_1870414_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd4/7850364/94a1e19ec468/TEMI_A_1870414_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd4/7850364/b3edc715fc88/TEMI_A_1870414_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd4/7850364/3abb1945018a/TEMI_A_1870414_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd4/7850364/c2326d555ca5/TEMI_A_1870414_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd4/7850364/8d3f6650e5c5/TEMI_A_1870414_F0007_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd4/7850364/9fde1f5caa39/TEMI_A_1870414_F0008_OC.jpg

相似文献

1
SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.SARS-CoV-2 的蛋白酶 PLpro 和 3CLpro 可切割 IRF3 以及炎症途径的关键调节剂(NLRP12 和 TAB1):对跨物种疾病表现的影响。
Emerg Microbes Infect. 2021 Dec;10(1):178-195. doi: 10.1080/22221751.2020.1870414.
2
SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.SARS-CoV-2 nsp5 表现出比其 SARS-CoV 同源物更强的催化活性和干扰素拮抗作用。
J Virol. 2022 Apr 27;96(8):e0003722. doi: 10.1128/jvi.00037-22. Epub 2022 Apr 7.
3
SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3.严重急性呼吸综合征冠状病毒2型主要蛋白酶通过阻止磷酸化干扰素调节因子3的核转位来抑制I型干扰素的产生。
Int J Biol Sci. 2021 Apr 10;17(6):1547-1554. doi: 10.7150/ijbs.59943. eCollection 2021.
4
SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response.SARS-CoV-2 Nsp5 采用两种不同机制靶向 RIG-I 和 MAVS 以逃避先天免疫反应。
mBio. 2021 Oct 26;12(5):e0233521. doi: 10.1128/mBio.02335-21. Epub 2021 Sep 21.
5
Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.中东呼吸综合征冠状病毒木瓜蛋白酶样蛋白酶的蛋白水解加工、去泛素化酶和干扰素拮抗活性。
J Gen Virol. 2014 Mar;95(Pt 3):614-626. doi: 10.1099/vir.0.059014-0. Epub 2013 Dec 20.
6
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.木瓜蛋白酶样蛋白酶调节新型冠状病毒2的病毒传播和固有免疫。
Nature. 2020 Nov;587(7835):657-662. doi: 10.1038/s41586-020-2601-5. Epub 2020 Jul 29.
7
SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense.SARS-CoV-2 主要蛋白酶切割 MAGED2 以拮抗宿主抗病毒防御。
mBio. 2023 Aug 31;14(4):e0137323. doi: 10.1128/mbio.01373-23. Epub 2023 Jul 13.
8
Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease.SARS-CoV-2 主蛋白酶对 TRMT1 tRNA 修饰酶的蛋白水解切割和失活。
Elife. 2024 May 30;12:RP90316. doi: 10.7554/eLife.90316.
9
Predicted coronavirus Nsp5 protease cleavage sites in the human proteome.预测人类蛋白质组中冠状病毒 Nsp5 蛋白酶的切割位点。
BMC Genom Data. 2022 Apr 4;23(1):25. doi: 10.1186/s12863-022-01044-y.
10
SARS-CoV-2 papain-like protease inhibits ISGylation of the viral nucleocapsid protein to evade host anti-viral immunity.SARS-CoV-2 木瓜蛋白酶样蛋白酶抑制病毒核衣壳蛋白的 ISG 化,从而逃避宿主抗病毒免疫。
J Virol. 2024 Sep 17;98(9):e0085524. doi: 10.1128/jvi.00855-24. Epub 2024 Aug 9.

引用本文的文献

1
Multitarget-based screening from phytoactive compounds of fighting toward severe acute respiratory syndrome coronavirus-2.基于多靶点从抗严重急性呼吸综合征冠状病毒2的植物活性化合物中进行筛选
Tzu Chi Med J. 2025 Apr 4;37(3):275-284. doi: 10.4103/tcmj.tcmj_226_24. eCollection 2025 Jul-Sep.
2
SADS-CoV nsp5 Inhibits Interferon Production by Targeting Kinase IKKε.严重急性呼吸综合征冠状病毒非结构蛋白5通过靶向激酶IKKε抑制干扰素产生。
Microorganisms. 2025 Jun 26;13(7):1494. doi: 10.3390/microorganisms13071494.
3
The coronavirus 3CL protease: Unveiling its complex host interactions and central role in viral pathogenesis.

本文引用的文献

1
Possibility for reverse zoonotic transmission of SARS-CoV-2 to free-ranging wildlife: A case study of bats.SARS-CoV-2 反向人畜共患病传播给野生动物的可能性:以蝙蝠为例的案例研究。
PLoS Pathog. 2020 Sep 3;16(9):e1008758. doi: 10.1371/journal.ppat.1008758. eCollection 2020 Sep.
2
Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2.SARS-CoV-2 木瓜蛋白酶样蛋白酶(PLpro)的作用机制及抑制作用。
EMBO J. 2020 Sep 15;39(18):e106275. doi: 10.15252/embj.2020106275. Epub 2020 Aug 26.
3
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.
冠状病毒3CL蛋白酶:揭示其复杂的宿主相互作用及在病毒发病机制中的核心作用。
Virol Sin. 2025 Aug;40(4):509-519. doi: 10.1016/j.virs.2025.07.002. Epub 2025 Jul 7.
4
Development of the coronavirus reverse genetic system: Core technology for pathogenesis mechanisms research and vaccine/drug development.冠状病毒反向遗传系统的发展:发病机制研究及疫苗/药物研发的核心技术
Virulence. 2025 Dec;16(1):2525930. doi: 10.1080/21505594.2025.2525930. Epub 2025 Jun 28.
5
Innate immunity, therapeutic targets and monoclonal antibodies in SARS-CoV-2 infection.新型冠状病毒感染中的固有免疫、治疗靶点及单克隆抗体
PeerJ. 2025 Jun 20;13:e19462. doi: 10.7717/peerj.19462. eCollection 2025.
6
The Role of TDP-43 in SARS-CoV-2-Related Neurodegenerative Changes.TDP-43在与SARS-CoV-2相关的神经退行性变化中的作用
Viruses. 2025 May 19;17(5):724. doi: 10.3390/v17050724.
7
The SARS-CoV-2 3CL protease inhibits pyroptosis through the cleavage of gasdermin D.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)3C样蛋白酶通过切割gasdermin D抑制细胞焦亡。
Virol Sin. 2025 Jun;40(3):324-332. doi: 10.1016/j.virs.2025.03.006. Epub 2025 Mar 19.
8
Interferon Regulatory Factor 3 Exacerbates the Severity of COVID-19 in Mice.干扰素调节因子3加剧小鼠新冠病毒病的严重程度
Crit Care Explor. 2025 Mar 17;7(3):e1225. doi: 10.1097/CCE.0000000000001225. eCollection 2025 Mar.
9
Anti-interferon armamentarium of human coronaviruses.人类冠状病毒的抗干扰素手段
Cell Mol Life Sci. 2025 Mar 13;82(1):116. doi: 10.1007/s00018-025-05605-z.
10
Innate Immunity Never "NODs" Off: NLRs Regulate the Host Anti-Viral Immune Response.固有免疫从不“打盹”:NLRs调节宿主抗病毒免疫反应。
Immunol Rev. 2025 Mar;330(1):e13429. doi: 10.1111/imr.13429.
木瓜蛋白酶样蛋白酶调节新型冠状病毒2的病毒传播和固有免疫。
Nature. 2020 Nov;587(7835):657-662. doi: 10.1038/s41586-020-2601-5. Epub 2020 Jul 29.
4
Porcine Deltacoronavirus nsp5 Cleaves DCP1A To Decrease Its Antiviral Activity.猪德尔塔冠状病毒 nsp5 切割 DCP1A 以降低其抗病毒活性。
J Virol. 2020 Jul 16;94(15). doi: 10.1128/JVI.02162-19.
5
SARS-CoV-2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children.SARS-CoV-2 诱导的川崎样超炎症综合征:儿童新型 COVID 表型。
Pediatrics. 2020 Aug;146(2). doi: 10.1542/peds.2020-1711. Epub 2020 May 21.
6
Artificial intelligence approach fighting COVID-19 with repurposing drugs.人工智能方法通过药物再利用抗击 COVID-19。
Biomed J. 2020 Aug;43(4):355-362. doi: 10.1016/j.bj.2020.05.001. Epub 2020 May 15.
7
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.宿主对 SARS-CoV-2 的失衡反应导致 COVID-19 的发生。
Cell. 2020 May 28;181(5):1036-1045.e9. doi: 10.1016/j.cell.2020.04.026. Epub 2020 May 15.
8
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.SARS-CoV-2 疫情意大年夜利中间爆发严重川崎病样病:一项不雅察性队列研究。
Lancet. 2020 Jun 6;395(10239):1771-1778. doi: 10.1016/S0140-6736(20)31103-X. Epub 2020 May 13.
9
Human coronaviruses with emphasis on the COVID-19 outbreak.以新冠疫情为重点的人类冠状病毒。
Virusdisease. 2020 Jun;31(2):80-84. doi: 10.1007/s13337-020-00594-y. Epub 2020 May 12.
10
Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency.严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的演变,作为 2019 年冠状病毒病(COVID-19)大流行:全球卫生紧急事件。
Sci Total Environ. 2020 Aug 15;730:138996. doi: 10.1016/j.scitotenv.2020.138996. Epub 2020 Apr 30.